http://orcid.org/0000-0002-3748-3742
References
- Bettelli E, Pagany M, Weiner HL, et al. (2003). Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med, 197, 1073–81.
- Bittner S, Afzali AM, Wiendl H, Meuth SG. (2014). Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice. J Vis Exp, 86. 2014 Apr, 15;(86). doi:10.3791/51275.
- Chanaday NL, Roth GA. (2016). Microglia and astrocyte activation in the frontal cortex of rats with experimental autoimmune encephalomyelitis. Neuroscience, 314, 160–69.
- Frid K, Einstein O, Friedman-Levi Y, et al. (2015). Aggregation of MBP in chronic demyelination. Ann Clin Transl Neurol, 2, 711–21.
- Hofstetter HH, Ibrahim SM, Koczan D, et al. (2005). Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol, 237, 123–30.
- Hofstetter HH, Shive CL, Forsthuber TG. (2002). Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund’s adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J Immunol, 169, 117–25.
- Leuenberger T, Paterka M, Reuter E, et al. (2013). The role of CD8+ T cells and their local interaction with CD4+ T cells in myelin oligodendrocyte glycoprotein35-55-induced experimental autoimmune encephalomyelitis. J Immunol, 191, 4960–68.
- Ministry of Science and Technology of China. (2006). The guide for the care and use of laboratory animals. http://www.most.gov.cn/fggw/zfwj/zfwj2006/200609/t20060930_54389.htm.
- McCarthy DP, Richards MH, Miller SD. (2012). Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler’s virus-induced demyelinating disease. Methods Mol Biol, 900, 381–401.
- Radu CG, Anderton SM, Firan M, et al. (2000). Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int Immunol, 12, 1553–60.
- Rangachari M, Kuchroo VK. (2013). Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun, 45, 31–39.
- Rangachari M, Zhu C, Sakuishi K, et al. (2012). Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med, 18, 1394–400.
- Robinson AP, Harp CT, Noronha A, Miller SD. (2014). The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol, 122, 173–89.
- Sinha S, Boyden AW, Itani FR, et al. (2015). CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis. Front Immunol, 6, 619.
- Sonobe Y, Jin S, Wang J, et al. (2007). Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J Exp Med, 213, 329–39.
- Steckner C, Weber A, Mausberg AK, et al. (2016). Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice. Clin Immunol, 170, 22–30.
- Tsunoda I, Kuang LQ, Theil DJ, Fujinami RS. (2000). Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol, 10, 402–18.
- Van Der Star BJ, Vogel DY, Kipp M, et al. (2012). In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets, 11, 570–88.
- Vanderlugt CL, Neville KL, Nikcevich KM, et al. (2000). Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol, 164, 670–78.